Therapeutic Exposures and Risk Factors in MRONJ
Launched by MARMARA UNIVERSITY · May 21, 2024
Trial Information
Current as of February 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a condition called medication-related osteonecrosis of the jaw (MRONJ), which can happen after using certain medications. The goal of the study is to observe patients who have this condition over time to learn more about how they are diagnosed, treated, and monitored. Researchers want to find out how factors like a patient’s background, lifestyle, and other health issues might affect their recovery and quality of life.
To participate in this trial, individuals must be 18 years or older and seeking treatment for MRONJ at the Marmara University Faculty of Dentistry. Both men and women can join, as long as they or their legal representatives provide written consent. Participants can expect to be closely monitored during the study, allowing researchers to gather important information that could help improve care for others with this condition in the future. It’s important to note that this study is not open to individuals with other types of jaw issues not related to medication, or those under 18 years of age.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals aged 18 and over
- • Male or female individuals
- • Individuals who apply to the Marmara University Faculty of Dentistry, Department of Oral and Maxillofacial Surgery due to medication-related osteonecrosis of jaw during the study period
- • Individuals or their legal representatives who have given written consent to participate in the study
- Exclusion Criteria:
- • Non-drug-related osteonecrosis/osteomyelitis
- • Osteoradionecrosis
- • Metastasis to the oral region
- • Individuals who have not given written consent to participate in the study
- • Individuals under the age of 18
Trial Officials
Ferit Bayram, PhD
Study Chair
Marmara University Faculty of Dentistry
About Marmara University
Marmara University is a distinguished academic institution located in Istanbul, Turkey, renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust infrastructure and a multidisciplinary approach, the university actively engages in the development and evaluation of new therapeutic interventions, fostering collaboration among researchers, clinicians, and industry partners. Marmara University’s focus on ethical standards and patient safety underscores its dedication to contributing valuable insights to the medical community and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0